These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 15709024

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
    Landrum ML, Roediger MP, Fieberg AM, Weintrob AC, Okulicz JF, Crum-Cianflone NF, Ganesan A, Lalani T, Macalino GE, Chun HM.
    J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1.
    Ren G, Esser S, Jochum C, Schlaak JF, Gerken G, Schadendorf D, Dittmer U, Wu G, Yuan Z, Timm J.
    AIDS; 2012 Nov 13; 26(17):2145-53. PubMed ID: 22948268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens.
    Hoff J, Bani-Sadr F, Gassin M, Raffi F.
    Clin Infect Dis; 2001 Mar 15; 32(6):963-9. PubMed ID: 11247719
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
    Lascar RM, Gilson RJ, Lopes AR, Bertoletti A, Maini MK.
    J Infect Dis; 2003 Dec 15; 188(12):1815-9. PubMed ID: 14673759
    [Abstract] [Full Text] [Related]

  • 12. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH, Hung CC, Chang SY, Liu CJ, Chen MY, Hsieh SM, Kao JH, Chen PJ, Chang SC.
    Clin Infect Dis; 2012 Feb 15; 54(4):548-55. PubMed ID: 22156858
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.
    Sherman AC, Trehanpati N, Daucher M, Davey RT, Masur H, Sarin SK, Kottilil S, Kohli A.
    AIDS Res Hum Retroviruses; 2013 Apr 15; 29(4):665-72. PubMed ID: 23259453
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana.
    Chadwick D, Ankcorn M, Sarfo F, Phillips R, Fox Z, Garcia A, Appiah L, Bedu-Addo G, Geretti AM.
    J Antimicrob Chemother; 2012 Dec 15; 67(12):2939-42. PubMed ID: 22915461
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F, Loggi E, Chisholm JV, Biselli M, Morelli MC, Cursaro C, Terrault NA, Bernardi M, Bertoletti A, Andreone P, Brander C.
    Liver Transpl; 2008 Apr 15; 14(4):478-85. PubMed ID: 18324666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.